(NASDAQ: TECH) Bio Techne's forecast annual revenue growth rate of 7.55% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 129.09%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.54%.
Bio Techne's revenue in 2025 is $1,208,769,000.On average, 5 Wall Street analysts forecast TECH's revenue for 2026 to be $203,152,542,848, with the lowest TECH revenue forecast at $198,613,659,356, and the highest TECH revenue forecast at $208,767,006,752.
In 2027, TECH is forecast to generate $219,191,561,567 in revenue, with the lowest revenue forecast at $217,094,642,229 and the highest revenue forecast at $222,401,058,398.